• 1. Department of Neurology, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou 510370, China;
  • 2. Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou 510370, China;
  • 3. Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China;
  • 4. Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;
NING Yuping, Email: ningjeny@126.com; ZHOU Liemin, Email: lmzhou56@163.com
Export PDF Favorites Scan Get Citation

Objective In order to evaluate that whether the P-glycoprotein-inhibitor verapamil (VPM) could effect the distribution of antiepileptic drug phenytoin (PHT) in a rat model of mesial temporal lobe epilepsy (MTLE).Methods The rat models of MTLE were induced by li-pilocarpine and were randomly divided into two groups (PHT group and VPM+PHT treatment group) to compare the PHT distribution in brain, liver and kidney. Brain dialysate samples were collected by microdialysis technology. And the analysis of samples for PHT concentration was performed by high performance liquid chromatography (HPLC). The comparisons were carried out by t test (or Wilcoxon test).Results In VPM+PHT treatment group, 4 out of 9 rats were dead within 30 minutes after drug administration. The significantly decreased area under the curve (AUC) ratio of brain/plasma in VPM+PHT group was 0.11±0.06 when compared with PHT group 0.21±0.02 (t=3.237, P=0.025), while there were no significant differences in ratios of liver/plasma [PHT (1.12±0.37) vs. VPM+PHT (0.99±0.27), Z=−0.490, P=0.624] and kidney/plasma [PHT (0.74±0.16) vs. VPM+PHT (0.49±0.26), t=1.872, P=0.103] between two groups.Conclusions The P-glycoprotein-inhibitor VPM significantly decreased PHT level in brain of rat with MTLE.

Citation: FANG Ziyan, WU Fengchun, CHEN Shuda, QIN Jiaming, NING Yuping, ZHOU Liemin. Effects of verapamil for phenytoin distribution in rat model with mesial temporal lobe epilepsy. Journal of Epilepsy, 2019, 5(3): 165-169. doi: 10.7507/2096-0247.20190029 Copy

  • Previous Article

    中国癫痫诊断治疗现状
  • Next Article

    Analysis of risk factors for cognitive dysfunction in patients with epilepsy